212 related articles for article (PubMed ID: 28138303)
1. Amino Acid Profiles of Serum and Urine in Search for Prostate Cancer Biomarkers: a Pilot Study.
Dereziński P; Klupczynska A; Sawicki W; Pałka JA; Kokot ZJ
Int J Med Sci; 2017; 14(1):1-12. PubMed ID: 28138303
[TBL] [Abstract][Full Text] [Related]
2. Prospective serum metabolomic profiling of lethal prostate cancer.
Huang J; Mondul AM; Weinstein SJ; Derkach A; Moore SC; Sampson JN; Albanes D
Int J Cancer; 2019 Dec; 145(12):3231-3243. PubMed ID: 30779128
[TBL] [Abstract][Full Text] [Related]
3. Determination of amino acids in urine of patients with prostate cancer and benign prostate growth.
Sroka WD; Boughton BA; Reddy P; Roessner U; Słupski P; Jarzemski P; Dąbrowska A; Markuszewski MJ; Marszałł MP
Eur J Cancer Prev; 2017 Mar; 26(2):131-134. PubMed ID: 27222937
[TBL] [Abstract][Full Text] [Related]
4. Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the Gleason score.
Markin PA; Brito A; Moskaleva N; Lartsova EV; Shpot YV; Lerner YV; Mikhajlov VY; Potoldykova NV; Enikeev DV; La Frano MR; Appolonova SA
Metabolomics; 2020 Jun; 16(7):74. PubMed ID: 32556743
[TBL] [Abstract][Full Text] [Related]
5. Quantitative urinary proteomics using stable isotope labelling by peptide dimethylation in patients with prostate cancer.
Li C; Zang T; Wrobel K; Huang JT; Nabi G
Anal Bioanal Chem; 2015 May; 407(12):3393-404. PubMed ID: 25724369
[TBL] [Abstract][Full Text] [Related]
6. Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.
Struck-Lewicka W; Kordalewska M; Bujak R; Yumba Mpanga A; Markuszewski M; Jacyna J; Matuszewski M; Kaliszan R; Markuszewski MJ
J Pharm Biomed Anal; 2015; 111():351-61. PubMed ID: 25684700
[TBL] [Abstract][Full Text] [Related]
7. The decrease of some serum free amino acids can predict breast cancer diagnosis and progression.
Eniu DT; Romanciuc F; Moraru C; Goidescu I; Eniu D; Staicu A; Rachieriu C; Buiga R; Socaciu C
Scand J Clin Lab Invest; 2019; 79(1-2):17-24. PubMed ID: 30880483
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of serum amino acid profiles' utility in non-small cell lung cancer detection in Polish population.
Klupczynska A; Dereziński P; Dyszkiewicz W; Pawlak K; Kasprzyk M; Kokot ZJ
Lung Cancer; 2016 Oct; 100():71-76. PubMed ID: 27597283
[TBL] [Abstract][Full Text] [Related]
9. A study of low-molecular-weight organic acid urinary profiles in prostate cancer by a new liquid chromatography-tandem mass spectrometry method.
Klupczynska A; Plewa S; Sytek N; Sawicki W; Dereziński P; Matysiak J; Kokot ZJ
J Pharm Biomed Anal; 2018 Sep; 159():229-236. PubMed ID: 29990890
[TBL] [Abstract][Full Text] [Related]
10. Urinary estrogen metabolites and prostate cancer risk: a pilot study.
Kosti O; Xu X; Veenstra TD; Hsing AW; Chu LW; Goldman L; Bebu I; Collins S; Dritschilo A; Lynch JH; Goldman R
Prostate; 2011 Apr; 71(5):507-16. PubMed ID: 20886539
[TBL] [Abstract][Full Text] [Related]
11. Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related Changes.
Puhka M; Takatalo M; Nordberg ME; Valkonen S; Nandania J; Aatonen M; Yliperttula M; Laitinen S; Velagapudi V; Mirtti T; Kallioniemi O; Rannikko A; Siljander PR; Af Hällström TM
Theranostics; 2017; 7(16):3824-3841. PubMed ID: 29109780
[TBL] [Abstract][Full Text] [Related]
12. Low serum dehydroepiandrosterone examined by liquid chromatography-tandem mass spectrometry correlates with poor prognosis in hormone-naïve prostate cancer.
Miyoshi Y; Uemura H; Umemoto S; Sakamaki K; Taguri M; Suzuki K; Shibata Y; Masumori N; Ichikawa T; Mizokami A; Sugimura Y; Nonomura N; Sakai H; Honma S; Harada M; Kubota Y
Prostate; 2016 Mar; 76(4):376-82. PubMed ID: 26616365
[TBL] [Abstract][Full Text] [Related]
13. NMR-based metabolomics analysis identifies discriminatory metabolic disturbances in tissue and biofluid samples for progressive prostate cancer.
Zheng H; Dong B; Ning J; Shao X; Zhao L; Jiang Q; Ji H; Cai A; Xue W; Gao H
Clin Chim Acta; 2020 Feb; 501():241-251. PubMed ID: 31758937
[TBL] [Abstract][Full Text] [Related]
14. Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer.
An Z; Chen Y; Zhang R; Song Y; Sun J; He J; Bai J; Dong L; Zhan Q; Abliz Z
J Proteome Res; 2010 Aug; 9(8):4071-81. PubMed ID: 20560663
[TBL] [Abstract][Full Text] [Related]
15. Quantification of candidate prostate cancer metabolite biomarkers in urine using dispersive derivatization liquid-liquid microextraction followed by gas and liquid chromatography-mass spectrometry.
Shamsipur M; Naseri MT; Babri M
J Pharm Biomed Anal; 2013; 81-82():65-75. PubMed ID: 23624158
[TBL] [Abstract][Full Text] [Related]
16. An analysis of urine and serum amino acids in critically ill patients upon admission by means of targeted LC-MS/MS: a preliminary study.
Mierzchała-Pasierb M; Lipińska-Gediga M; Fleszar MG; Lewandowski Ł; Serek P; Płaczkowska S; Krzystek-Korpacka M
Sci Rep; 2021 Oct; 11(1):19977. PubMed ID: 34620961
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study.
Rehman I; Azzouzi AR; Catto JW; Allen S; Cross SS; Feeley K; Meuth M; Hamdy FC
Urology; 2004 Dec; 64(6):1238-43. PubMed ID: 15596215
[TBL] [Abstract][Full Text] [Related]
18. Elevated Metabolites of Steroidogenesis and Amino Acid Metabolism in Preadolescent Female Children With High Urinary Bisphenol A Levels: A High-Resolution Metabolomics Study.
Khan A; Park H; Lee HA; Park B; Gwak HS; Lee HR; Jee SH; Park YH
Toxicol Sci; 2017 Dec; 160(2):371-385. PubMed ID: 28973422
[TBL] [Abstract][Full Text] [Related]
19. Possibility of multivariate function composed of plasma amino acid profiles as a novel screening index for non-small cell lung cancer: a case control study.
Maeda J; Higashiyama M; Imaizumi A; Nakayama T; Yamamoto H; Daimon T; Yamakado M; Imamura F; Kodama K
BMC Cancer; 2010 Dec; 10():690. PubMed ID: 21176209
[TBL] [Abstract][Full Text] [Related]
20. Identification of the metabolic signatures of prostate cancer by mass spectrometry-based plasma and urine metabolomics analysis.
Yu C; Niu L; Li L; Li T; Duan L; He Z; Zhao Y; Zou L; Wu X; Luo C
Prostate; 2021 Dec; 81(16):1320-1328. PubMed ID: 34590739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
